HealthTimes

Community Response Features Gender Matrix

Zim Women Doctors Making Waves

Michael Gwarisa

IN the beginning, the medical profession was sacred ground and somehow, a preserve for men. However over the years, women have made remarkable contributions to the field of medicine. As women around the world were permitted to graduate from medical schools, their accomplishments became more influential and far-reaching. In 1847, Dr. Elizabeth Blackwell became the

Read More
1PortiaHunidzarira
Health News HIV/AIDS

Mutating HIV Virus Making It Difficult To Develop Vaccine

Michael Gwarisa

THE ever-changing genetic makeup and rapid mutation of the HIV virus has to a larger extent slowed down progress towards successfully developing an effective HIV vaccine, a top Zimbabwean expert has said. By Michael Gwarisa The revelations also follow the recent abandonment of the Imbokodo HIV vaccine or HVTN 705/HPX2008 efficacy studies after revelations that

Read More
Health News HIV/AIDS

Imbokodo HIV Vaccine Study Was A Learning Phase

Michael Gwarisa

Dr Portia Hunidzarira, the Imbokodo Principal Researcher said the discontinuation of the HVTN 705/HPX2008 or Imbokodo study gave researchers and scientist a new platform to learn and develop evidence  for future studies that might lead to an HIV vaccine breakthrough. By Patricia Mashiri She said the vaccine proved to be safe and caused no harm

Read More
Dr Portia Hunidzarira, University of Zimbabwe, Clinical Health Science (CHS)-Clinical Trials Research Centre (CTRC) in March walked journalists on the vaccine roadmap.
Health News

Oxford, Wits Universities Conducting ÇOVID-19 Vaccine Trails

Michael Gwarisa

THE Oxford University is running COVID-19 Vaccine Clinical Trials in collaboration with Wits University of South Africa. The vaccine was developed at the University of Oxford’s Oxford Jenner Institute and is currently on trial in the UK. Over 4 000 participants are already enrolled into the clinical trial and enrolment of an additional 10 000

Read More